PRESSEMITTEILUNGEN

Pleasanton, Kalifornien (ots/PRNewswire) – – Die Tests verändern das Management von Hepatitis-C-Erkrankungen und der Patienten Roche (SIX: RO, ROG; OTCQX: RHHBY) gab heute bekannt, dass seine neuesten, technisch führenden qualitativen und quantitativen Hepatitis-C-Virus (HCV) Tests die CE-Kennzeichnung erhalten haben. Die Tests weisen HCV-RNA nach, einen wichtigen Marker beim Management von Hepatitis-C-Infektionen. Im neuen Zeitalter der [...]

Continue reading

Dr Paul, Hcv Rna, Hepatitis, Hepatitis C, Hepatitis C Virus, Hepatitis Virus, Iu, Kalifornien, Kennzeichnung, Marker, Molecular Diagnostics, Ots, Paul Brown, Qualitative Test, Quantitative Test, Roche Diagnostics, Roche Molecular, Rog, Virus Hcv, Werkzeug

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Berlin, Germany, and Seattle, WA, U.S.A., January 4, 2012 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, is pleased to announce that it has submitted [...]

Continue reading

American Cancer, Approval Application, Berlin Germany, Colorectal Cancer, Document Guidance, Epigenomics Ag, Fda Staff, Food And Drug Administration, Food And Drug Administration Fda, Guidance Document, Inferiority, Molecular Diagnostics, Premarket Approval, Prime Standard, Quality Controls, Regulatory Approval, Screening Test, Study Protocol, Submission Protocol, Us Food And Drug Administration

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/molecular diagnostics 09.12.2011 Berlin, Germany, December 9, 2011 – Epigenomics AG (ISIN: DE000A1K0516) reports the completion of the clinical validation study [...]

Continue reading

Berlin Germany, Cancer Cases, Clinical Performance, Clinical Validation, Colonoscopy, Colorectal, Colorectal Cancer, Disease Specificity, Epigenomics Ag, Food And Drug Administration, Food And Drug Administration Fda, German Securities Trading Act, Independent Laboratories, Molecular Diagnostics, Plasma Samples, Regulatory Approval, Screening Guidelines, Securities Trading Act, Study Subjects, Validation Study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Subtitle: Conference Call Scheduled for today, 9thDecember 2011 at 4 pm CET Berlin, Germany, and Seattle, WA, U.S.A., December 9, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer [...]

Continue reading

Adhoc, Berlin Germany, Cancer Cases, Clinical Performance, Clinical Validation, Colonoscopy, Colorectal, Colorectal Cancer, Diagnostic Company, Disease Specificity, Eans, Epigenomics Ag, Independent Laboratories, Molecular Diagnostics, Plasma Samples, Prime Standard, Regulatory Approval, Screening Guidelines, Study Subjects, Validation Study

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Company Information/molecular diagnostics Subtitle: Epigenomics to host a corporate workshop on advances in blood-based colorectal cancer screening; ARUP Laboratories will present independent data for its laboratory-developed Septin9 test Grapevine, TX, U.S.A., November 16, 2011 (euro [...]

Continue reading

Adjunct Assistant Professor, American Cancer, Arup Laboratories, Biomarker, Cancer Cases, Cancer Screening, Colorectal Cancer, Corporate Workshop, Epigenomics Ag, Grapevine Texas, Grapevine Tx, Independent Data, Interpretation Algorithm, Ldt, Molecular Diagnostics, Molecular Pathology, Plasma Marker, Test Interpretation, University Of Utah School Of Medicine, Utah School

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– New Products/Company Information/molecular diagnostics Subtitle: Presentation of the powerful second generation blood test for colorectal cancer screening during UEGW in Stockholm Berlin, Germany, and Stockholm, Sweden, October 25, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime [...]

Continue reading

Adhoc, Berlin Germany, Blood Test, Cancer Detection, Cancer Screening, Clinical Validation, Colorectal, Colorectal Cancer, Epigenomics Ag, European Gastroenterology, Invasive Method, Launch, Molecular Diagnostics, New Test, Positive Predictive Value, Ppv, Prime Standard, Second Generation, Stockholm Sweden, Uegw

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/New Products/molecular diagnostics Subtitle: Study provides clinical evidence for CE-marking in Europe and paves way to US pivotal clinical trial for submission to FDA before year-end Berlin, Germany, and Seattle, WA, USA, September 19, 2011 [...]

Continue reading

Adhoc, Ag Reports, Berlin Germany, Cancer Cases, Clinical Evidence, Colonoscopy, Colorectal, Colorectal Cancer, Epigenomics, Food And Drug Administration, Molecular Diagnostics, Pivotal Clinical Trial, Prime Standard, Product Validation, Seattle Wa Usa, Second Generation, Significant Improvement, Specificity, Therapeutic Interventions, Validation Study

Pleasanton, Kalifornien (ots/PRNewswire) – – Test zur Bestimmung der cobas BRAF-Mutation erkennt Melanome, bei denen eine genetische Mutation vorliegt, die eine Behandlung mit Zelboraf (Vemurafenib) ermöglicht Roche (SIX: RO, ROG; OTCQX: RHHBY) gab heute bekannt, dass der cobas BRAF-Mutationstest jetzt in Europa und anderen Ländern, die die CE-Kennzeichnung anerkennen, im Handel erhältlich ist. Der cobas [...]

Continue reading

Als, Ein, Europa, Genetische Mutation, Handel, Kalifornien, Klinische, Medikament, Melanom, Mit, Molecular Diagnostics, Ots, Paul Brown, Pleasanton, Prnewswire, Roche Diagnostics, Roche Molecular, Rog, Zurzeit

Amsterdam (ots/PRNewswire) – – Agendia Publishes Prospectus and Sets Indicative IPO Price Range – Not for Release, Distribution or Publication in Whole or in Part, Directly or Indirectly, into or in The United States, Australia, Canada, or Japan This announcement is not a prospectus but an advertisement and nothing herein contains an offering of securities. [...]

Continue reading

Agendia, Allotment, Australia Canada, Commercial Stage, Euronext Amsterdam, Free Float, Initial Public Offering, Initial Public Offering Ipo, Institutional Investors, Ipo Price Range, Market Capitalisation, Molecular Diagnostics, Nyse Euronext, Ordinary Shares, Ots, Prnewswire, Prospectus, Regulated Market, Release Distribution, Retail Investors

Pleasanton, Kalifornien (ots/PRNewswire) – – Der cobas(R) TaqScreen MPX Test, v2.0(1) liefert Echtzeit-Resultate für HIV, HCV und HBV Roche (SIX: RO, ROG; OTCQX: RHHBY) kündigte heute an, dass der cobas(R) TaqScreen MPX Test, version 2.0 für den Einsatz auf dem cobas s 201-System ab jetzt in Europa im Handel erhältlich sei. Diese neueste Version des [...]

Continue reading

Cobas, Hbv, Hcv Rna, Hepatitis B, Hepatitis B Virus, Hepatitis C, Hepatitis C Virus, Hiv Hcv, Human Immunodeficiency Virus, Kennzeichnung, Molecular Diagnostics, Ots, Paul Brown, Prnewswire, Rna Hiv, Roche, Rog, Screening Test, Test Version, Virus Hcv

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Annual & Special Corporate Meetings/Company Information/molecular diagnostics Berlin, Germany, May 18, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer molecular diagnostics company, today issued invitations to its Annual General Shareholders´ Meeting scheduled [...]

Continue reading

Adhoc, Balance Sheet, Berlin Germany, Concomitant, Convocation, Corporate Meetings, Corporate News, Corporation Act, Depreciation, Epigenomics, Gap, German Gap, German Stock, Molecular Diagnostics, Prime Standard, Reverse Stock Split, Share Capital, Shareholders Meeting, Stock Corporation, Supervisory Board

Health economic analysis in favor of Septin9 testing presented by renowned Stanford University researcher at Digestive Disease Week 2011 Patient behavior study underway to demonstrate compliance benefit ——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company Information/molecular diagnostics Subtitle: Health economic analysis in favor [...]

Continue reading

Behavior Study, Berlin Germany, Cancer Epidemiology, Colorectal Cancer Screening, Digestive Disease Week, Dna Methylation, Effective Health, Fecal Occult Blood, Fecal Occult Blood Testing, Free Dna, Gastroenterology And Hepatology, Markov Model, Medical Benefit, Molecular Diagnostics, Occult Blood Testing, Prime Standard, Redwood City Ca, Seattle Wa Usa, Stanford University, University Researcher

——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Personnel/Molecular diagnostics Berlin, Germany, and Seattle, WA, USA, April 20, 2011 (euro adhoc) – Epigenomics AG (Frankfurt Prime Standard: ECX), the cancer diagnosis company, today announced the appointment of Noel Doheny as the new Chief Executive [...]

Continue reading

Affymetrix Inc, Analytical Solutions, Berlin Germany, Cancer Diagnosis, Chief Executive Officer, Ciba Corning, Commercial Strategy, Georgetown University, Market Approval, Molecular Diagnostics, Novel Products, Opgen, Post Graduate Studies, Pre Market, Prime Standard, Qiagen, Seattle Wa Usa, Senior Vice President, Thermobiostar, West Virginia University

——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. ——————————————————————————– New Products/Molecular diagnostics 28.02.2011 Berlin, Germany, February 28, 2011 – Epigenomics AG (ISIN: DE000A0BVT96) today signed an option agreement in colorectal cancer [...]

Continue reading

Amp, Berlin Germany, Biomarker, Biomarkers, Blood Test, Blood Testing, Collaboration Agreement, Collection Of Clinical Specimens, Colorectal, Colorectal Cancer, Dna Methylation, Epigenomics Ag, German Securities Trading Act, Isin, Molecular Diagnostics, Option Agreement, Qiagen, Sample Preparation, Securities Trading Act, Upfront Payment